These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 837312)

  • 1. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guide to the management of rubella problems.
    Middleton PJ; Larke RP; Lessard P; Doran TA
    Can Med Assoc J; 1977 Mar; 116(5):484-8. PubMed ID: 837313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of rubella prevention in Austria (1988 status)].
    Hofmann H; Kunz C
    Wien Med Wochenschr; 1989 Jul; 139(14):330-3. PubMed ID: 2773490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella vaccination. An evolving problem for obstetrics and gynecology.
    Monif GR
    Obstet Gynecol; 1972 Feb; 39(2):304-7. PubMed ID: 5057800
    [No Abstract]   [Full Text] [Related]  

  • 5. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of pregnant women to rubella and the implications of immunization programs].
    Villalbí JR; Graells C; Marín T
    An Esp Pediatr; 1988 Feb; 28(2):137-40. PubMed ID: 3355032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
    Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L
    Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of rubella virus infections.
    Iwakata S; Rhodes AH; Labzoffsky NA
    Can Med Assoc J; 1973 Apr; 108(7):894-5 passim. PubMed ID: 4581796
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in antibody titre after rubella vaccination in primarily rubella-sera positive parturient women. Demonstration of antigen-specific (rubella) and non-specific stimulated antibody titres (author's transl)].
    Doerr HW; Geisen HP; Kapp M; Schmidt W
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1316-20. PubMed ID: 6257468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccination of young women against rubella, mainly in the post-partum period].
    Zourbas J; Toulouse R; Colombani J; Esmieu F; Buil M; Hamonou M
    Rev Fr Gynecol Obstet; 1970 Mar; 65(3):107-13. PubMed ID: 5442694
    [No Abstract]   [Full Text] [Related]  

  • 11. Rubella antibody titres and immunization status in a family practice.
    Mills DA; Parker KR; Evans CE
    Can Med Assoc J; 1980 Mar; 122(5):549-52. PubMed ID: 7370858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On vaccination against rubella with live attenuated virus (strain RA 27-3)].
    Monaci V; Giovannelli G; Nardi G; Siegert V; Tanzi ML; Bellelli E; Chiusi O
    Ann Sclavo; 1974; 16(3):231-42. PubMed ID: 4473961
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rubella immunization--immunity after 4 years (author's transl)].
    Petersen EE; Neumann-Haefelin D; Kärnbach M; Haas R
    Dtsch Med Wochenschr; 1977 Jul; 102(26):954-8. PubMed ID: 885075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rubella embryopathy, still now? (author's transl)].
    Enders G
    Geburtshilfe Frauenheilkd; 1982 May; 42(5):403-13. PubMed ID: 6921121
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-rubella vaccination with Plotkin strain].
    Monnet P; Nicolas A; Lang R
    Presse Med (1893); 1970 Jan; 78(3):107-9. PubMed ID: 5418580
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination with RA 27-3 rubella vaccine. Persistence of immunity and resistance to challenge after two years.
    Liebhaber H; Ingalls TH; Le Bouvier GL; Horstmann DM
    Am J Dis Child; 1972 Feb; 123(2):133-6. PubMed ID: 4554549
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Passive immunization against rubella: studies on the effectiveness of rubella-immunoglobulin after intranasal infection with rubella vaccination virus].
    Neumann-Haefelin D; Neumann-Haefelin Ch; Petersen EE; Luthardt Th; Hass R
    Dtsch Med Wochenschr; 1975 Jan; 100(5):177-81. PubMed ID: 1112230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.